BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 33030089)

  • 1.
    Slade GD; Fillingim RB; Ohrbach R; Hadgraft H; Willis J; Arbes SJ; Tchivileva IE
    J Dent Res; 2021 Feb; 100(2):163-170. PubMed ID: 33030089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of catechol-O-methyltransferase polymorphism on response to propranolol therapy in chronic musculoskeletal pain: a randomized, double-blind, placebo-controlled, crossover pilot study.
    Tchivileva IE; Lim PF; Smith SB; Slade GD; Diatchenko L; McLean SA; Maixner W
    Pharmacogenet Genomics; 2010 Apr; 20(4):239-48. PubMed ID: 20216107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of comorbid migraine on propranolol efficacy for painful TMD in a randomized controlled trial.
    Tchivileva IE; Ohrbach R; Fillingim RB; Lim PF; Giosia MD; Ribeiro-Dasilva M; Campbell JH; Hadgraft H; Willis J; Arbes SJ; Slade GD
    Cephalalgia; 2021 Jun; 41(7):839-850. PubMed ID: 33560875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COMT Diplotype Amplifies Effect of Stress on Risk of Temporomandibular Pain.
    Slade GD; Sanders AE; Ohrbach R; Bair E; Maixner W; Greenspan JD; Fillingim RB; Smith S; Diatchenko L
    J Dent Res; 2015 Sep; 94(9):1187-95. PubMed ID: 26198390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. µ-Opioid Activity in Chronic TMD Pain Is Associated with COMT Polymorphism.
    Nascimento TD; Yang N; Salman D; Jassar H; Kaciroti N; Bellile E; Danciu T; Koeppe R; Stohler C; Zubieta JK; Ellingrod V; DaSilva AF
    J Dent Res; 2019 Nov; 98(12):1324-1331. PubMed ID: 31490699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulp Sensitivity: Influence of Sex, Psychosocial Variables, COMT Gene, and Chronic Facial Pain.
    Mladenovic I; Krunic J; Supic G; Kozomara R; Bokonjic D; Stojanovic N; Magic Z
    J Endod; 2018 May; 44(5):717-721.e1. PubMed ID: 29550002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of gene polymorphisms in catechol-O'methyltransferase (COMT) and β2-adrenergic receptor (ADRB2) with temporomandibular joint disorders.
    Ekici Ö; Arıkan Söylemez ES
    Arch Oral Biol; 2024 Feb; 158():105859. PubMed ID: 38043362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic Polymorphisms of Catechol-O-Methyltransferase: Association with Temporomandibular Disorders and Postoperative Pain.
    Mladenovic I; Supic G; Kozomara R; Dodic S; Ivkovic N; Milicevic B; Simic I; Magic Z
    J Oral Facial Pain Headache; 2016 Fall; 30(4):302-310. PubMed ID: 27792797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of a pilot multicenter genotype-based randomized placebo-controlled trial of propranolol to reduce pain after major thermal burn injury.
    Orrey DC; Halawa OI; Bortsov AV; Shupp JW; Jones SW; Haith LR; Hoskins JM; Jordan MH; Bangdiwala SI; Roane BR; Platts-Mills TF; Holmes JH; Hwang J; Cairns BA; McLean SA
    Clin J Pain; 2015 Jan; 31(1):21-9. PubMed ID: 25084070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of propranolol for treatment of temporomandibular disorder pain: a randomized, placebo-controlled clinical trial.
    Tchivileva IE; Hadgraft H; Lim PF; Di Giosia M; Ribeiro-Dasilva M; Campbell JH; Willis J; James R; Herman-Giddens M; Fillingim RB; Ohrbach R; Arbes SJ; Slade GD
    Pain; 2020 Aug; 161(8):1755-1767. PubMed ID: 32701836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Painful Temporomandibular Disorder: Decade of Discovery from OPPERA Studies.
    Slade GD; Ohrbach R; Greenspan JD; Fillingim RB; Bair E; Sanders AE; Dubner R; Diatchenko L; Meloto CB; Smith S; Maixner W
    J Dent Res; 2016 Sep; 95(10):1084-92. PubMed ID: 27339423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid and Dopamine Genes Interact to Predict Naltrexone Response in a Randomized Alcohol Use Disorder Clinical Trial.
    Anton RF; Voronin KE; Book SW; Latham PK; Randall PK; Glen WB; Hoffman M; Schacht JP
    Alcohol Clin Exp Res; 2020 Oct; 44(10):2084-2096. PubMed ID: 32772383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of genetic risk related to catechol-O-methyltransferase (COMT) and β2-adrenergic receptor (ADRB2) activity in different diagnostic subgroups of temporomandibular disorder in Brazilian patients.
    de Souza Tesch R; Ladeira Bonato L; Quinelato V; Ladeira Casado P; Rezende Vieira A; Granjeiro JM; Góes C
    Int J Oral Maxillofac Surg; 2020 Feb; 49(2):237-243. PubMed ID: 31285095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of catechol-O-methyltransferase polymorphisms on pain is modified by depressive symptoms.
    Schwahn C; Grabe HJ; Meyer zu Schwabedissen H; Teumer A; Schmidt CO; Brinkman C; Kocher T; Nauck M; Völzke H; Biffar R; Bernhardt O
    Eur J Pain; 2012 Jul; 16(6):878-89. PubMed ID: 22337325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of catechol-O-methyltransferase (rs4680) single-nucleotide polymorphism on opioid-induced hyperalgesia in adults with chronic pain.
    Hooten WM; Hu D; Cunningham JM; Black JL
    Mol Pain; 2019; 15():1744806919848929. PubMed ID: 31041874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epistasis between polymorphisms in COMT, ESR1, and GCH1 influences COMT enzyme activity and pain.
    Smith SB; Reenilä I; Männistö PT; Slade GD; Maixner W; Diatchenko L; Nackley AG
    Pain; 2014 Nov; 155(11):2390-9. PubMed ID: 25218601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of oral behaviours and psychological factors with selected genotypes in pain-related TMD.
    Zlendić M; Vrbanović E; Tomljanović M; Gall Trošelj K; Đerfi KV; Alajbeg IZ
    Oral Dis; 2024 Apr; 30(3):1702-1715. PubMed ID: 37036392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant Brain Signal Variability and COMT Genotype in Chronic TMD Patients.
    Lim M; Nascimento TD; Kim DJ; Ellingrod VL; DaSilva AF
    J Dent Res; 2021 Jul; 100(7):714-722. PubMed ID: 33622085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catechol-O-methyltransferase (COMT) gene polymorphisms as risk factor in temporomandibular disorders patients from Southern Italy.
    Michelotti A; Liguori R; Toriello M; D'Antò V; Vitale D; Castaldo G; Sacchetti L
    Clin J Pain; 2014 Feb; 30(2):129-33. PubMed ID: 23446089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of comorbid migraine and temporomandibular disorders: a factorial, double-blind, randomized, placebo-controlled study.
    Goncalves DA; Camparis CM; Speciali JG; Castanharo SM; Ujikawa LT; Lipton RB; Bigal ME
    J Orofac Pain; 2013; 27(4):325-35. PubMed ID: 24171182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.